Incyte, NewLink Genetics Crash into Friday’s 52-Week Low Club
Incyte, NewLink Genetics, McDermott International, and Williams Companies all posted new 52-week low Friday.
Incyte, NewLink Genetics, McDermott International, and Williams Companies all posted new 52-week low Friday.
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Thursday was a strong day for the U.S. markets, with all three of the major exchanges hitting all-time highs yet again. Earnings season is just around the corner, and starting Friday we…
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should…
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Monday was a relatively positive day for the three major U.S. exchanges, but trading volumes were low as this is a truncated trading week. Crude oil was negative on the day. The…
The S&P 500 index closed up about 0.5% Wednesday on a day that saw all three major indexes finish on the up side.
Overall Monday was a relatively flat day for the broad markets. Despite crude oil sliding lower on the day, Oil & Gas stocks were relatively mixed, with the likes of Exxon actually…
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
Although Wednesday was the worst trading day that the markets have seen in 2016, Thursday the broad markets made a handy recovery. All of the sectors were positive in the index with…
The top analyst upgrades, downgrades and other research calls on Friday include Ambac, Bed Bath & Beyond, General Electric, Tiffany and Trade Desk.
When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and biotech companies can see harsh punishment.